Hemex
Investor profile
Hemex has backed 4 European tech companies across 5 funding rounds between 2020 and 2025, joining rounds totalling €17M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
5
distinct rounds
Companies
4
backed
Active span
2020–2025
6 yrs
Total round €
€17M
sum of rounds joined
Deals by year
distinct rounds / yearHemex — deals by year — interactive chart.
Data table
| Hemex — deals by year | |
|---|---|
| 2020 | 1 |
| 2022 | 3 |
| 2025 | 1 |
Top sectors
by dealsHemex — top sectors — interactive chart.
Data table
| Hemex — top sectors | |
|---|---|
| Healthtech | 5 |
Stages
by dealsHemex — stages — interactive chart.
Data table
| Hemex — stages | |
|---|---|
| Other | 1 |
| Pre-Seed | 1 |
| Seed | 1 |
| Series A | 1 |
| Series B | 1 |
Countries
by dealsHemex — countries — interactive chart.
Data table
| Hemex — countries | |
|---|---|
| Switzerland | 5 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Hemotune AG | Switzerland | 1 | €7.1M |
| Aspivix | Switzerland | 1 | €4.8M |
| Bottneuro | Switzerland | 1 | €4.1M |
| Annaida Technologies | Switzerland | 2 | €928k |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Hemotune AG | Series B | €7.1M | 2022-04 |
| Aspivix | Series A | €4.8M | 2022-11 |
| Bottneuro | Other | €4.1M | 2022-12 |
| Annaida Technologies | Seed | €928k | 2020-09 |